Atherogenic Index in Type 2 Diabetes and Its Relationship with Chronic Microvascular Complications

Table 1

Baseline data analysis across groups.

	AIP Q1	AIP Q2	AIP Q3
Range	< −0.13	−0.13–0.23	≥ 0.23
Cases	592	1076	855
Sex (M/F)	329/263	622/454	402/453
Hypertension (Y/N)	293/299	452/624	306/549
DM family history (Y/N)	169/423	272/804	229/626
Body weight (kg)	64.50 ± 10.68	68.5 ± 11.36	69.55 ± 10.09
BMI (kg/m^2)	23.90 ± 4.39	25.30 ± 3.43	25.79 ± 3.27
Waist circumference (cm)	89.39 ± 30.67	91.49 ± 11.53	92.77 ± 13.86
Hip circumference (cm)	95.84 ± 11.17	97.29 ± 11.22	99.32 ± 9.37
WHR	0.92 ± 0.08	0.93 ± 0.10	0.94 ± 0.09
Systolic pressure (mmHg)	142.68 ± 12.96	139.17 ± 11.72	137.26 ± 11.29
Diastolic pressure (mmHg)	82.19 ± 10.22	79.16 ± 9.47	75.28 ± 8.27
FBS (mmol/L)	7.96 ± 3.12	8.52 ± 3.05	9.17 ± 3.24
PPBS (mmol/L)	13.41 ± 5.24	14.31 ± 5.46	15.30 ± 5.42
HbA1c	8.16 ± 2.01	8.2 ± 1.95	8.71 ± 1.82
FINS (μU/mL)	15.7 ± 5.90	18.06 ± 6.17	20.19 ± 11.22
PINS (μU/mL)	53.47 ± 10.33	55.09 ± 15.25	63.52 ± 12.75
HOMA-IR	2.42 ± 0.53	3.47 ± 0.81	4.00 ± 0.82
HOMA-β	61.80 ± 15.44	65.45 ± 13.35	66.59 ± 15.20
BUN (mmol/L)	6.21 ± 2.84	5.96 ± 2.33	6.24 ± 2.28
Cr (μmol/L)	74.47 ± 15.04	74.83 ± 13.06	77.85 ± 17.71
UA (μmol/L)	288.50 ± 44.81	308.71 ± 46.86	331.76 ± 41.35
eGFR (mL/min∙1.73 m^2)	93.99 ± 28.66	93.52 ± 31.44	92.84 ± 33.07
TG (mmol/L)	0.81 ± 0.27	1.35 ± 0.44	2.84 ± 0.98
HDL-C (mmol/L)	1.58 ± 0.53	1.17 ± 0.41	0.98 ± 0.22

M: male; F: female; DM: diabetes mellitus; BMI: body mass index; WHR: waist-to-hip ratio; FBS: fasting blood glucose; PPBG: postprandial blood glucose; HbA1c: hemoglobin A1c; FINS: fasting insulin; PINS: postprandial insulin; UA: uric acid; BUN: blood urea nitrogen; Cr: creatine; eGFR: estimated glomerular filtration rate; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol. Compared with AIP Q1 group, .